Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases

By Cimino Ashley  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 701-708

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of EpCAM/MUC1 mRNA-positive cells in non-small cell lung cancer patients

By Zhu Wen-Fang   Li Jian   Yu Li-Chao   Wu Yian   Tang Xin-Ping   Hu Yi-Ming   Chen Yong-Chang  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1211-1219

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

By Sebastian Martin   Passlick Bernward   Friccius-Quecke Hilke   Jäger Michael   Lindhofer Horst   Kanniess Frank   Wiewrodt Rainer   Thiel Eckhard   Buhl Roland   Schmittel Alexander  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 10, 2007-10 ,pp. : 1637-1644

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway

By            

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 651-658

Spandidos Publications

Access to resources Recommend Favorite

High Ep-CAM Expression is Associated with Poor Prognosis in Node-positive Breast Cancer

By Spizzo Gilbert  

Breast Cancer Research and Treatment, Vol. 86, Iss. 3, 2004-08 ,pp. : 207-213

Springer Publishing Company

Access to resources Recommend Favorite